Podcasts about GE Healthcare

Condensation in an anesthesia circuit looks harmless until it starts skewing flow sensor readings or creating the kind of warm, wet environment where microbes can thrive. We pick up the story after the investigation into moisture and mold concerns in GE operating room ventilators, then move straight into the questions clinicians asked most: which filters matter, how low-flow anesthesia changes the moisture equation, and what “moisture mitigation” actually means at the bedside.We walk through APSF guidance on filtration, including why a high-quality filter between the expiratory limb and the anesthesia machine is a key defense for keeping respiratory pathogens out of the workstation. We also talk about what HME filters do well for airway humidity and reducing moisture entering the machine, where their limits are (especially moisture generated by CO2 absorption), and why sidestream gas sampling lines deserve more attention in infection prevention and anesthesia machine protection.Then we share GE Healthcare's response, including what's universal across modern anesthesia breathing systems, what features support moisture management, and when optional condensers may help depending on clinical usage patterns.If this topic affects your OR workflow, subscribe, share the episode with a colleague, and leave a review so more anesthesia professionals can find these moisture management and patient safety insights.For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/310-moisture-matters-in-anesthesia-circuits/© 2026, The Anesthesia Patient Safety Foundation

Was medical physicist an option at your school's career day? If so, lucky you! But if not, you're not alone. It's a pretty niche field, but it has a significant impact on the future of personalized medicine and treating diseases. If you're thinking that this sounds like an intriguing career path, we're joined by physicists working in several different areas of nuclear medicine: quality control, equipment calibration, and research. Ben Auer, PhD, hosts this episode as we learn more about how our guests discovered their career in medical physics, the qualifications needed, and the various opportunities that come with this highly rewarding field. Tune in now!This episode of the Podcast is sponsored by GE HealthCare.Vizamyl Important Safety InformationPRODUCT INDICATIONS AND USEVIZAMYL™(flutemetamol F 18 injection) is indicated for positron-emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for:Evaluation of Alzheimer's disease(AD) and other causes of cognitive declineSelection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing of information of the therapeutic products.CONTRAINDICATIONSVIZAMYL is contraindicated in patients with a history of hypersensitivity reaction to VIZAMYL or polysorbate 80.ADVERSE REACTIONSThe most commonly reported adverse reactions in clinical trials were flushing(2%), increased blood pressure(2%), headache nausea and dizziness(1%).Postmarketing experience included anaphylactic reactions. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.Prior to VIZAMYL administration, please read the full Prescribing Information for additional Important Safety Information: https://gehealthcare.com/vizamyl-pi Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

One third of all data generated globally comes from the healthcare sector, yet a staggering 97% of it remains unused, trapped in siloed systems. This "big crime" of wasted potential is exactly what Simon Rost and his team at GE Healthcare are determined to solve. As the Global Marketing Officer for Enterprise Imaging, Simon sits at the helm of a business that touches over a billion patients a year. In a world where medical imaging is the bedrock of diagnosis, the challenge isn't just about capturing the image anymore—it's about what we do with the intelligence hidden within it. In this episode, Simon breaks down the transition from "Big Iron" hardware to the invisible power of enterprise medical imaging software. We dive into the rise of Agentic AI—AI that doesn't just analyze but takes action—and how GE Healthcare is moving toward a future of autonomous imaging to free up clinicians for what matters most: the patient. We also explore the critical shift in commercial models from CapEx (capital expenditure) to SaaS (software-as-a-service), the necessity of an open ecosystem over "walled gardens," and why interoperability must be the innovation of the decade. Simon even shares a personal anecdote about how GE's technology bookended the birth of his son, bringing the scale of MedTech down to the most human level. Whether you are a radiologist, a healthtech entrepreneur, or a data enthusiast, this conversation is a masterclass in how a global giant is retooling for the AI-first era of medicine! Timeline: 00:00:00 - Simon's journey in MedTech and enterprise imaging software at GE Healthcare 00:05:50 - The trends of AI in healthcare from Simon's perspective 00:12:04 - Where AI and hardware meet in medical devices 00:14:35 - Positioning GE Healthcare's portfolio along the end-to-end patient journey 00:20:27 - How GE Healthcare builds the value proposition and commercial models of its enterprise imaging software 00:28:15 - GE Healthcare's philosophy regarding partnerships and building ecosystems 00:33:37 - Simon's predictions for the future of medical imaging What we also talked about with Simon: Healthcare Information and Management Systems Society (HIMSS) GE Healthcare's Hello AI Program We mentioned with Simon some of the past episodes of the series: #16 - Making ultrasound portable to transform medical imaging - Ohad Arazi - Clarius #32 - Accelerating radiology with AI - Amine Korchi - Radiologist #36 - Turning healthcare preventive with full-body MRI scans - Andrew Lacy - Prenuvo #47 - Pushing responsible AI in health - Dr. Ricardo Baptista Leite - HealthAI As mentioned by Simon during the episode, you can have a read at Ground Truths by Dr. Eric Topol and his recent book Super Agers, offering exhaustive and evidence-based insights on the science of longevity, and the role medical imaging in it. Simon also recommends checking out The Medical Futurist website by Dr. Bertalan Meskó, a bible for everything around medical technology and the latest innovations in the space. You can get in touch with Simon via LinkedIn, and follow GE Healthcare's activities on their website, LinkedIn, Facebook, Instagram, X, and YouTube. ✉️ If you want to give me feedback on the episode or suggest potential guests, contact me over LinkedIn or via email! ⭐️ And if you liked the episode, please share it, subscribe to the podcast, and leave a 5-star review on streaming platforms!

Black particles in a breathing system are the kind of finding that makes every anesthesia professional stop and look twice. We're sharing what a large health system uncovered after concerns for mold and moisture accumulation surfaced inside certain GE Healthcare anesthesia workstations used in operating rooms, especially during longer cases and in humid conditions. What started with a routine inspection quickly scaled into a broad audit of OR ventilators, a review of internal moisture points, and an urgent push for real-world mitigation.We walk through what the investigation found, what cultures grew, and the question everyone asks first: what is the risk to patients? We discuss why the available evidence suggests the infectious risk is likely minimal when high-quality heat and moisture exchange (HME) filtration and breathing circuit filters are used correctly, and why the team still pulled affected machines from service for sterilization per manufacturer instructions. Patient safety isn't only about infection, though, and we also cover how excess condensate can affect flow sensors and tidal volume accuracy.Then we get concrete about prevention. We break down where moisture comes from inside an anesthesia ventilator, how low-flow anesthesia and rebreathing can increase water production in the circuit, and why simply turning up fresh gas flow isn't the right fix when cost and environmental impact matter. You'll hear the day-to-day moisture mitigation strategies that were implemented, including education, routine moisture and mold checks, overnight handling of circuits and sensors, and why add-on condenser drainage may be necessary for older compatible models.If you want a practical checklist mindset for anesthesia workstation maintenance, OR ventilator safety, and moisture management, this is for you. Subscribe, share with your colleagues, and leave a review so more teams can spot problems early and keep patients safe.For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/309-mold-risk-in-anesthesia-workstations/© 2026, The Anesthesia Patient Safety Foundation

India's medical devices industry is entering a high‑growth phase, with the market set to expand from USD 14 billion today to nearly USD 30 billion by 2030. With India ranking among the top 20 MedTech markets globally, the healthcare ecosystem is taking several steps and initiatives that are steering the country toward sustained growth in the sector. In this episode, we are joined by Raghavendra Rao, Chief Operating Officer – Distribution, Wipro GE Healthcare, who highlights that demand, a supportive public‑policy environment, and the shift from reactive care to early prediction are three key pillars that will drive India's MedTech opportunity. He also reflects on the company's journey of ‘Make in India, for India, and for the World' and how GE HealthCare plans to build on this momentum going forward.

OxygenCare, a leading Irish medical device distributor with over 54 years of experience supporting anaesthesia and critical care, has announced the Irish launch of the GE Carestation 850 Anaesthesia Delivery System at the College of Anaesthesiologists of Ireland (CAI) Annual Congress, held in O'Reilly Hall, UCD. The launch marks a significant milestone in OxygenCare's long-standing partnership with Irish healthcare, reflecting more than five decades of innovation supporting clinicians, from early gas delivery systems to today's connected, data-driven care environments. As the exclusive Irish distributor for GE HealthCare's anaesthesia portfolio, OxygenCare is introducing the GE Carestation 850 as a Digital for Care-ready platform, aligned with the HSE's evolving digital infrastructure, including the One Health Record (National EHR), NIMIS, and future integrated care systems. "The theme of this year's CAI Congress, 'The Evolution of Anaesthesia and Critical Care', perfectly reflects our journey," said Maurice Moran, Managing Director, OxygenCare. "For over 50 years, we have enabled Irish clinicians to deliver safer, more effective care as technology has evolved. The GE Carestation 850 represents the next step: advanced clinical performance combined with seamless digital integration, fully aligned with HSE Digital for Care standards. We are proud to launch it here among the clinicians shaping the future of anaesthesia in Ireland." Designed for Ireland's Digital Healthcare Ecosystem The GE Carestation 850 is built as a fully connected medical device, supporting the transition from paper-based workflows to a data-driven, integrated perioperative environment. Key Digital Features include: Interoperability by Design: Simplifying connections to other medical devices and to hospital networks. Real-time data transmission can be configured to automatically send important physiological, machine and service data to various clients simultaneously. Integrated Care Connectivity: Bi-directional data exchange with Shared Care Record and future Community Care Record. Cybersecurity Framework: Future-ready: Extra computing power to accommodate smart tools and features. AI-Ready Architecture: Supports future decision tools such as predictive alerts and ventilation optimisation. Advanced Clinical Performance The GE Carestation 850 is engineered to support the evolving demands of anaesthesia and critical care: Advanced ventilation modes for both low-flow and high-flow anaesthetic techniques. High-resolution touchscreen interface for intuitive operation and rapid clinical decision-making. Efficient vapouriser and gas management systems. Native integration with anaesthesia information systems and hospital PAS. End-tidal control (Et Control) Automatically adjusts fresh gas flows to maintain EtO2 and EtAA targets. The new GE Carestation 850 is a platform for today and for the future – engineered with digital architecture that supports ongoing software innovations while delivering advanced clinical performance combined with seamless digital integration.The system will be displayed at the CAI Congress, continuing OxygenCare's long-standing commitment to engage directly with Ireland's anaesthesia community. See more stories here. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help promote your business. Why not drop us a line at Info@IrishTechNews.ie now to find out more about how we can help you reach our audience. You can also find and follow us on Twitter, LinkedIn, Facebook, Instagram, TikTok and Snapchat.

In der heutigen Folge sprechen die Finanzjournalisten Lea Oetjen und Holger Zschäpitz über resiliente Börsen, das „graue Nashorn“ in China und ein dickes Versprechen bei Qualcomm. Außerdem geht es um Alphabet, Amazon, Microsoft, Meta, Robinhood, Bloom Energy, Plug Power, Fuelcell Energy, Siemens Healthineers, GE HealthCare, Adidas, Scout24, Mercedes-Benz, Deutsche Bank, DWS, Inovance, Siasun Robot & Automation, Estun Automation, iShares Automation & Robotics ETF (WKN: A2ANH0) und L&G ROBO Global Robotics and Automation ETF (WKN: A12DB1). Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Hier könnt ihr den AAA-Newsletter abonnieren: https://www.welt.de/newsletter/article232797673/Alles-auf-Aktien-Der-taegliche-Boersen-Newsletter-fuer-WELTplus-Abonnenten.html Und - ganz neu: AAA gibt es jetzt auch auf Instagram: https://www.instagram.com/alles_auf_aktien/ Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Why do so many great MedTech products stall after launch — even when the data is there? In this episode of Med Tech Gurus, we're joined by Amy Brouhle, Vice President of Strategic Business Development at S2N Health. A former emergency department nurse turned commercialization leader, Amy brings more than 20 years of experience spanning clinical care, GPO strategy, national accounts, and MedTech growth. Her career includes senior roles at Vizient, Hillrom, and GE Healthcare, giving her a rare, end-to-end view of how innovation actually gets adopted — or stuck. At S2N Health, Amy helps MedTech companies cut through the noise of fragmented data and turn insight into action. We explore why most organizations don't have a data problem — they have an insight problem — and how aligning sales, marketing, and strategy around the right signals can unlock utilization, accelerate adoption, and improve investor confidence. From GPO dynamics and channel strategy to AI-powered targeting, territory planning, and go-to-market execution, Amy shares practical lessons every founder and commercial leader needs to hear. If you're trying to translate innovation into revenue and scale, this is a conversation you won't want to miss.

Episode 175: Veronica Lynn Clark, M.S. and her book, To Be Aligned: Getting Clear on Your Higher PurposeABOUT VERONICAVeronica Lynn Clark is a trailblazer in personal transformation, intimacy empowerment, and somatic healing. With nearly two decades of experience, she has guided countless individuals in reclaiming their power, healing from trauma, and living with greater authenticity and purpose. Her work blends deep compassion with profound expertise, creating transformative spaces where individuals feel safe to explore vulnerability and step into their fullest selves.A certified Somatic Experiencing Practitioner, Intimacy Coach, and Transformational Speaker, Veronica is known for demystifying complex emotional and relational dynamics while providing practical tools for healing and self-discovery. She is also a yoga and meditation teacher and the best-selling author of To Be Aligned: Getting Clear on Your Higher Purpose and Better Sex, Less Drama (series)Veronica has led workshops and retreats at venues such as Civana Wellness Resort and Spa, collaborated with organizations including Google, GE Healthcare, and Thrivos, and has been featured on the Today Show for her expertise in personal growth and wellness.CONVERSATION HIGHLIGHTS• Veronica's inspiring background: from banking and real estate to healing and self-love• How childhood trauma and a mental health crisis shaped her path to healing• The role of mindfulness, yoga, and sacred sexuality in her transformation• Her approach to self-concept, values, and living aligned with your highest purpose• The creation and evolution of her book, To Be Aligned, as a tool for self-discovery• Insights into leadership: honesty, accountability, humility, and leading with love• The power of storytelling and owning your unique life journey• Upcoming retreats, trainings, and the launch of her audiobookThe MAIN QUESTION for you that comes out of my conversation with Veronica is, What is the highest vision you have for yourself, and what's stopping you from attaining it?FIND VERONICA• LinkedIn: https://www.linkedin.com/in/veronicalclark/• Website: www.veronicalynnclark.com• The Better Sex, Less Drama™ Series: https://www.veronicalynnclark.com/better-sex-less-drama-book-series• Instagram: https://www.instagram.com/veronicalclark/LinkedIn - Full Podcast Article: CHAPTERS00:00 - The Book Leads Podcast - Veronica Lynn Clark00:50- Introduction & Bio01:59 - Who are you today? Can you provide more information about your work?03:37 - How did your path into your career look like, and what did it look like up until now?06:49 - Veronica & Volunteer Work30:24 - How does the work you're doing today reconcile to who you were as a child?33:03 - What is your superpower?35:17 - What does leadership mean to you?40:46 - Can you introduce us to the book we're discussing?48:06 - Can you provide a general overview of the book?59:25 - What's changed in you in the process of writing this book?01:02:11 - What book has inspired you?01:05:11 - What are you up to these days? (A way for guests to share and market their projects and work.)This series has become my Masterclass In Humanity. I'd love for you to join me and see what you take away from these conversations.Learn more about The Book Leads and listen to past episodes:· Watch on YouTube· Listen on Spotify· Listen on Apple Podcasts· Read About The Book Leads – Blog PostFor more great content, check out the catalog for my newsletter Last Week's Leadership Lessons, if you haven't already!

Host Justin Barnes records live at HIMSS26 in Las Vegas. Stay tuned for the next few weeks to hear all his guests.This week, Simon Philip Rost, Chief Marketing Officer, GE HealthCare and Charles Barkey, Vice President Information Technology – Northern Panhandle WVU Medicine Hospitals. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode, Brent Lavin shares how two decades in product and portfolio management at GE Healthcare, C.R. Bard, and BD shaped his mission to help Series A and B medtech startups build commercial logic into every stage of innovation. Brent breaks down what surprised him most moving from strategics to early-stage teams and why large companies often operate like startups when resources must be earned through influence, not authority. The conversation dives into how his engineering training powers a structured, “marketing-as-a-science” approach to product management, the most-missed elements of customer discovery, and a concrete example of winning by simplifying a “Cadillac” product into a segmented solution. Brent also unpacks what strategics look for in acquisitions plus lessons from LSI, leadership, and the discipline of endurance running.Brent Lavin LinkedInIronwood Medtech Partners LinkedInDuane Mancini LinkedInProject Medtech WebsiteProject Medtech LinkedInThank you to our sponsors: Ward Law and JumpStart Inc.

This year, 125.6 million people tuned in to watch the Seahawks face the Patriots in the Super Bowl. While the game was the main draw, it's perhaps the one time of year that commercials generate equal excitement. 2026 was no exception, but before the first quarter ended, it was clear which industry dominated the 2026 ad buys: artificial intelligence. AI has become ubiquitous in daily life, and there's almost no industry that hasn't been impacted by its adoption, including nuclear medicine. While some of its applications are clear, questions remain about how AI will be used in clinical settings, patient interactions, image interpretation, and more. On this episode of the SNMMI Podcast, Lance Burrell moderates a discussion with Dmitry Beyer, MPA, CNMT, and Samantha Heasty on AI and its capabilities, potential, and shortcomings. Tune in now!This episode of the SNMMI Podcast is sponsored by GE Healthcare.Important Safety Information – VIZAMYLPRODUCT INDICATIONS AND USEVIZAMYL™ (flutemetamol F 18 injection) is indicated for positron-emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for:· Evaluation of Alzheimer's disease (AD) and other causes of cognitive decline· Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing of information of the therapeutic products.CONTRAINDICATIONSVIZAMYL is contraindicated in patients with a history of hypersensitivity reaction to VIZAMYL or polysorbate 80.ADVERSE REACTIONSThe most commonly reported adverse reactions in clinical trials were flushing (2 %), increased blood pressure (2 %), headache (1 %), nausea and dizziness (1 %). Postmarketing experience included anaphylactic reactions. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.Prior to VIZAMYL administration, please read the full Prescribing Information for additional Important Safety Information: https://gehealthcare.com/vizamyl-piWant more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Stacey Tank is a 20+ year Fortune 500 veteran and currently Chief Executive Officer for Bespoke Beauty Brands (BBB), owner of high-growth cosmetics brands Jason Wu Beauty and KimChiChic Beauty, which can be found in places like Target, CVS, Walmart, JCPenney, Amazon, the TikTok Shop and beyond. BBB was founded in 2019 by serial entrepreneur Toni Ko who sold her first cosmetics company, NYX, to L'Oreal. Prior to BBB, Tank was based in Amsterdam in the role of Chief Transformation Officer for HEINEKEN (AMS: HEIA) with €29 billion in annual revenues and over 100,000 employees. As a direct report to the CEO and member of the executive committee, Tank co-created and later shepherded the company's growth strategy, "EverGreen," to ensure the organization adapted amidst a rapidly changing environment including a focus on top quartile growth and multi-billion euro cost out. In addition, Tank was responsible for the company's sustainability strategy, Brew a Better World 2030, including the design of its net zero carbon ambition. Tank formerly led the multi-billion dollar Home Depot Installation Services and Home Depot Measurement Services businesses for The Home Depot (NYSE: HD), the world's largest home improvement retailer with $132 billion in sales and 500,000 employees. During her tenure, Tank led the exit of four unprofitable lines of business and returned the remaining businesses to double-digit growth while strengthening the organization's culture, talent bench and innovation pipeline. Dedicated to the intersection of business and positive impact on society, Tank has repeatedly authored large-scale movements across enterprises like General Electric, HEINEKEN and The Home Depot including launching a quarter-of-a-billion-dollar commitment to veteran housing and a $50 million shop class program that is infusing 20,000 skilled tradespeople into the US economy. Before joining The Home Depot, Tank was a Senior Vice President for HEINEKEN USA @StaceyTank Stacey.M.Tank@gmail.com (AMS: HEIA), the leading importer of upscale beers in the US. Tank reported to thenCEO Dolf van den Brink and as part of the company's management team, navigated a difficult and successful turnaround period. Previously, from 2002 to 2011, Tank worked at General Electric (NYSE: GE), where she held a variety of global finance, audit, communications and marketing roles across GE Healthcare, NBC Universal, GE Capital, GE Energy, GE Aviation and GE Corporate (including GE's Communications Leadership Development Program and Corporate Audit Staff) in countries including Mexico, Brazil, Germany, the UK, France, Canada and the US. Tank is the founder of Our Happy Place (OurHappy.org), a 501(c)3 non-profit serving children, educators and families navigating childhood mental wellness. She also sits on the board, audit and compliance committees for Blackstone-owned Interior Logic Group, the leading US installer of interior finishes for new home construction. Tank previously sat on the boards of the Heineken Africa Foundation, American Chamber of Commerce in the Netherlands, Woodruff Arts Center (nominating and governance chair), Serenbe Playhouse, Ad Council, Home Depot Foundation (former president), Homer Fund, Bright Pink (executive board), Academy for Systems Change (finance committee), Arthur W. Page Society (digital committee), Westchester Business Council, Beer Institute, Institute for Public Relations and Subrosa (sold in late 2017). She is the former vice chairwoman of the National Association of Beverage Importers and the former chairwoman of the Heineken Good Government Fund. Tank is a 2020 World Economic Forum Young Global Leader (YGL), a 2019 Henry Crown Fellow at the Aspen Institute and a 2014 Academy for Systems Change Fellow. She graduated summa cum laude with a Bachelor of Science from Syracuse University's Newhouse School and Whitman School of Management where she was recognized as a University Scholar, the university's highest academic honor. Tank has been married for nearly 20 years and has three sons, two human and one canine.

Staffing shortages. Growing waitlists. Fixed capacity. Radiology leaders are running out of room to experiment, and AI is moving from “nice to have” to operational necessity.In this interview, Roland Rott, CEO and President of Imaging at GE Healthcare, explains why health systems are rethinking how AI fits into daily radiology operations. The focus is not on future promises, but on how AI is already being used to save time, reduce friction, and turn long-unused data into practical workflow improvements. The discussion spans staffing constraints, trust in AI, and why operational impact is now driving adoption.

In this episode of the Medical Sales Podcast, host Samuel Adeyinka sits down with Marie Robert, a GE Healthcare product sales specialist, to break down what it's really like selling capital medical equipment in one of the most competitive markets in the world. Marie shares how she entered the industry through GE's Commercial Leadership Program, what a day in the life of a New York City medical sales rep looks like, and how selling anesthesia machines requires deep hospital relationships, strategic thinking, and constant collaboration with physicians, procurement teams, and biomedical engineers. She also discusses the realities of working in a large corporate environment, the future of medical sales in an AI driven world, and the mindset, discipline, and resilience needed to succeed in this fast paced and highly competitive industry. Connect with Marie Robert: LinkedIn Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How »

In this episode, host Sandy Vance chats with Hari Bala, the Chief Technology Officer for Health Information Systems at Solventum. Together, they explore how healthcare organizations can build trust and confidence around AI adoption, drawing on insights from Solventum's recent global survey of healthcare professionals. The research highlights a growing demand for AI alongside concerns that innovation could increase pressure on clinicians. Hari shares practical perspectives on how AI can support rather than overshadow providers, improve efficiency without compromising quality, and help organizations introduce new technologies in ways that feel safe and sustainable. Listen to learn how leaders can ensure clinicians feel comfortable incorporating AI into their daily workflows while improving the overall patient experience. In this episode, they talk about: The three key trust factors and why trust is the foundation for AI adoption Why trust is the currency of successful implementation The role of AI in improving patient care and clinician efficiency How speed and quality can improve together rather than compete Key findings from Solventum's healthcare AI adoption survey The cultural and mindset shifts required for successful implementation The impact of AI on the patient experience How leaders can evaluate potential technology partners A Little About Hari: Hari Bala joined Solventum as Chief Technology Officer for Health Information Systems in May 2025. He brings more than 25 years of experience building scalable, distributed systems using generative AI, data science, analytics, and machine learning across healthcare, cloud, and security. Before Solventum, Hari led AI, data, analytics, and cloud transformation initiatives at GE Healthcare and Oracle Cerner. At Oracle, he helped establish the AI Services organization and led development of the Health Data Intelligence and Analytics platform, a near real-time, cloud-based population health solution, while advancing AI and machine learning tools for clinical use. Earlier in his career, Hari spent nearly 19 years at Microsoft in leadership roles across Azure and several core enterprise technologies.

Radiology teams don't need more dashboards. They need clearer signals about capacity, and better image quality. This conversation looks at how small, practical changes, powered by AI, make a real difference.In this video, Lily Belcak, Customer Success Leader at GE Healthcare, explains how analyzing DICOM data directly from imaging devices helps health systems better understand how long exams actually take and where schedules can be adjusted. The result is more accurate appointment planning and improved access without adding staff or equipment.You'll also hear from Laura Hernandez, Chief Marketing Officer for Women's Health and X-ray at GE Healthcare, on how Pristina Recon DL focuses on image clarity and reading efficiency. Clearer images support faster reads for radiologists and reduce the need for repeat scans, especially in breast imaging where precision matters.

So much of what we know about heart health is based on male models. Classic heart attack symptoms describe the experiences of men, drugs were developed largely by men for men—even in research, mouse models were male. But in recent years, our understanding of women's cardiac health has expanded, and critically, we have learned that we cannot simply apply male models to female patients. As one of our guests says, "women are not small men." For American Heart Month, join us for a heart-to-heart with members of the SNMMI Cardiovascular Council as they discuss how nuclear cardiology is providing new insight into women's heart health. Listen here or wherever you stream your podcasts. This episode of the SNMMI Podcast is sponsored by GE Healthcare.Important Safety Information – VIZAMYLPRODUCT INDICATIONS AND USEVIZAMYL™ (flutemetamol F 18 injection) is indicated for positron-emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for:· Evaluation of Alzheimer's disease (AD) and other causes of cognitive decline· Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing of information of the therapeutic products.CONTRAINDICATIONSVIZAMYL is contraindicated in patients with a history of hypersensitivity reaction to VIZAMYL or polysorbate 80.ADVERSE REACTIONSThe most commonly reported adverse reactions in clinical trials were flushing (2 %), increased blood pressure (2 %), headache (1 %), nausea and dizziness (1 %). Postmarketing experience included anaphylactic reactions. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.Prior to VIZAMYL administration, please read the full Prescribing Information for additional Important Safety Information: https://gehealthcare.com/vizamyl-pi

What separates companies that scale smoothly from those stuck in constant firefighting mode? Hector Sanchez, founder of PCK Partners with 18 years leading supply chain and procurement teams at GE Healthcare and major aerospace manufacturers, reveals it's not the processes—it's the people, and more specifically, how you lead them. In this conversation with Vince Perry, Hector breaks down how he slashed employee turnover from 30% to 8% without throwing money at the problem, just by fundamentally changing the culture. From coaching high school soccer to leading multi-million dollar transformations, Hector explains why the fundamentals of great leadership are identical whether you're on the field or in the boardroom. He shares the exact moment he realized that loud voices in the room aren't always the smartest ones, and how empowering his quietest team member became the key to driving change faster. You'll discover why breaking big visions into small, incremental wins gets buy-in while grand announcements create resistance, and the critical question he asks teams to make them realize changes need to happen—without him having to demand it. Hector pulls back the curtain on the biggest mistake founders make when hiring executives (hint: you can't retain control and expect top talent to succeed), why living your core values matters infinitely more than posting them on a wall, and the surprising truth about working with an $8 million business versus a $60 million operation. Whether you're running a collision shop, a nonprofit, or a Fortune 500 division, Hector proves that a business is a business—it just has fewer zeros. If you're tired of watching talented people walk out the door or struggling to get your team aligned on the vision, this episode delivers the leadership toolkit you've been missing. Thank you for being a vital part of our channel

In this episode of the HR Leaders Podcast, we sit down with David Sperl, Head of HR for Advanced Visualization Solutions at GE HealthCare, to unpack how HR earns real business credibility by shipping outcomes, not PowerPoints, inside a heavily regulated, science driven environment.David explains why AI literacy must move from theory to hands-on practice, how microlearning and shared baseline tools help drive adoption, and why leadership advocacy is essential to scale change across technical, clinical, and commercial teams. He breaks down GE HealthCare's four stages of AI adoption, how communities of practice create demand pull, and why unlearning outdated mental models is now harder than learning new ones.Most importantly, he shares why user experience and friction removal are the real unlocks for AI in HR and business, and why the future of change isn't “change management”, it's change agility.

In this episode, host Sandy Vance sits down with Parminder Bhatia , the Chief AI Officer from GE HealthCare , for a thoughtful, forward-thinking conversation about the rapidly shifting landscape of AI in healthcare. Together, they explore why healthcare is so ready for transformation, the four critical areas where change is most urgent, and how smarter systems can ease some of the industry's most complex workflows. Sandy and Parminder dig into how foundation models and the rise of agentic AI can finally help healthcare move beyond fragmented solutions. In this episode, they talk about:How AI is transforming a healthcare industry that's long overdue for changeThe four key areas where transformation is most neededStreamlining some of the most complex medical processesHow better communication and information can assist clinicians during labor and deliveryUsing foundation models to reduce fragmentation in healthcare AISupporting the multi-step workflows of radiologistsWhy agentic AI represents the future of healthcare innovationA Little About Parry:At GE HealthCare, Parry is focused on integrating AI across smart devices, across the patient journey, and at the hospital operations level. The company is a long-time leader in healthcare AI, topping the FDA's list of AI-enabled devices for four consecutive years with more than 115 authorizations. Parry's team advances AI within medical devices to improve patient outcomes, and he also serves on the company's responsible AI committee to ensure new solutions are reliable, scalable, and ethical. His work has earned recognition from Modern Healthcare's 40 Under 40, the AIM AI 100 Awards, and Constellation Research's AI 150. Before joining GE HealthCare, Parry was Head of Applied Science at Amazon, contributing to machine learning and generative AI products such as Amazon Comprehend Medical. He previously held AI and machine learning roles at Microsoft and Georgia Tech. He holds a B.S. in Computer Science from the Indian Institute of Technology and an M.S. in Computational Science and Engineering from the Georgia Institute of Technology.

In this episode, host Sandy Vance and Hari Balasubramanian, the Chief Technology Officer, Health Information Systems at Solventum, sit down for a deep dive into how AI-driven healthcare technology is reshaping the industry. Together, they explore how Solventum is building innovative products and services that streamline documentation, billing, and coding while improving the patient experience and saving valuable time for healthcare professionals. From what's happening at Solventum right now to the company's move toward fully autonomous coding, this conversation unpacks how healthcare payers and providers can rethink financial performance in the age of artificial intelligence. Hari also shares practical insights for CIOs evaluating these systems and explains how Solventum measures real-world improvements driven by AI. If you're interested in healthcare innovation, revenue cycle transformation, or the future of AI in health information systems, this is an episode you won't want to miss.Check out Solventum's Education Session and Case Study Session that was presented in the AI Zone at HLTH 2025.In this episode, they talk about:What's going on with Solventum right nowHow Solventum is serving healthcare payersSolventum's move toward complete autonomous codingThe common misconceptions about improving financial performance for providersHow CIOs should evaluate their work when engaging with these systemsMeasuring the improvements produced by AI with Solventum's systemsA Little About Hari:Hari Bala joined Solventum as Chief Technology Officer, Health Information Systems, in May 2025, bringing more than 25 years of experience building large-scale, distributed systems across healthcare, cloud, and security, with deep expertise in GenAI, data science, analytics, and machine learning. Previously, he led AI, data, analytics, and cloud transformation efforts at GE Healthcare and Oracle Cerner, where he helped establish Oracle's AI Services organization and later led the Health Data Intelligence and Analytics platform following the Cerner acquisition. Earlier, Hari spent nearly 19 years at Microsoft in leadership roles spanning Azure, Search, Cosmos DB, Windows, Office 365, and mobile and browser technologies.

La santé des femmes a longtemps été reléguée au second plan. Aujourd'hui, je reçois Cecilia Olsson, une femme au parcours bouleversant et inspirant, qui milite pour une médecine plus équitable. Après avoir surmonté un cancer du sein à 42 ans, elle transforme cette épreuve en moteur d'engagement. Chez GE Healthcare, elle œuvre pour améliorer le dépistage et intégrer la voix des patientes dans la conception des solutions. Son témoignage est à la fois celui d'une ancienne patiente et d'une actrice du changement dans le système de santé. Une conversation essentielle sur les inégalités de genre, la puissance du vécu, et les outils d'un avenir plus juste pour les femmes.Dans cet épisode, on parle de :Son parcours de soin et les chiffres marquants de son combat contre le cancerL'écriture comme outil de reconstruction et de prise de pouvoirLe rôle de GE Healthcare dans l'innovation au service des femmesL'importance du dépistage, notamment chez les femmes jeunesLe biais de genre dans la recherche et ses conséquences concrètesLes technologies comme levier d'un meilleur accompagnementCheminements, c'est le podcast santé des femmes qui parlent de leur santé mentale, physique, et émotionnelle, sans honte, sans filtre et sans tabou. Chaque épisode, diffusé un lundi sur deux, vous plonge dans des récits authentiques et bouleversants.En ouvrant le dictionnaire, on apprend que "cheminement" désigne une progression graduelle, un mouvement, une avancée. Dans ce podcast, le cheminement est celui des femmes : leurs luttes, leurs victoires et leurs transformations face aux défis de la vie et de la santé.Dans Cheminements, le micro est tendu à des femmes du quotidien : vos voisines, collègues, soeurs ou amies. Elles témoignent de leur santé mentale, physique ou sociale, partagent leurs parcours uniques et osent enfin lever le voile sur des sujets trop souvent passés sous silence.Ce podcast santé donne la parole à celles qui méritent d'être entendues. Chaque histoire, portée avec sincérité, met en lumière des réalités humaines, parfois douloureuses, mais toujours humaines.

Host Dr. Linda Chu speaks with Dr. Jana Ivanidze and Dr. Rajiv Magge about how molecular imaging is transforming the diagnosis and management of breast cancer brain metastases, with an emphasis on precision and personalized care. Their discussion highlights emerging tools such as advanced PET techniques and liquid biopsy that support earlier detection, guide treatment planning, and shape the future of neuro-oncology. Sponsored by GE HealthCare.      

At a recent Crain's event, hospital CEOs warned of fraying health care safety nets in the year ahead. Crain's health care reporter Jon Asplund talks with host Amy Guth about where local health care leaders say they are planning their focus in the year ahead.Plus: Feds warn CTA to boost policing or lose transit funding, Mars wins unconditional EU nod for $36B Kellanova deal, United Airlines CEO Kirby nets nearly $13M in first big stock sale and GE HealthCare touts slate of new tech plus collaboration with Mayo Clinic. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Desiree Chappell and Sol Aronson discuss innovations in anesthesia at ANESTHESIOLOGY® 2025 with Brandon Henak, Global Marketing Director, Monitoring Solutions at GE Healthcare and John W Beard, Chief Medical Officer at GE Healthcare - Patient Care Solutions. They unveil GE's new premium anesthesia platform designed for both current and future needs, emphasizing enhanced workflow, patient safety, and adaptable technology. The conversation highlights the platform's advanced features, including a dual compute architecture, innovative vaporization system, and digital solutions for improved perioperative care. Find out more here: https://www.gehealthcare.co.uk/products/perioperative-care/carestation-850 Listen to more of John W Beard here: https://topmedtalk.libsyn.com/cost-savings-through-continuous-vital-sign-monitoring-anes23 And find more of Brandon Henak here: https://topmedtalk.libsyn.com/tom-westrick-and-brandon-henak-from-ge-healthcare-topmedtalk

Send us a textGood morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we'll explore the latest advances and strategic moves shaping the industry, providing you with insights into how these developments might influence drug development and patient care.The pharmaceutical and biotech sectors are currently experiencing a wave of transformative changes. A significant development is the trade agreement between the United States and the United Kingdom, which excludes medicines from import tariffs. This strategic move, orchestrated by the Trump administration, is set to reduce costs and bolster investments in pharma sectors across both nations. By enhancing market accessibility, it aims to stimulate cross-border investment in pharmaceutical research and production.On the clinical front, Eli Lilly is making headlines by joining Novo Nordisk in reducing self-pay prices for its GLP-1 receptor agonist, Zepbound. This reflects a broader industry trend towards patient-centric pricing models aimed at improving affordability. With healthcare costs on the rise, these measures could ease financial burdens for patients requiring long-term medication regimens.Regulatory updates are also making waves, with the FDA planning stricter vaccine regulations under Dr. Vinay Prasad's leadership at the Center for Biologics Evaluation and Research (CBER). These updates come amid concerns over vaccine safety during COVID-19-related incidents, underscoring a commitment to maintaining public trust in vaccines. Regulatory scrutiny continues as Prasad focuses on COVID-19 vaccine safety in children amid reports linking 10 child deaths to vaccines via VAERS—emphasizing challenges interpreting safety data while highlighting the need for robust methodologies ensuring reliable causality conclusions.In corporate restructuring news, Valneva is streamlining its operations by closing a site and eliminating 30 roles. This move highlights an industry focus on optimizing resources to bolster vaccine development pipelines. Meanwhile, Microsize and Schedio's acquisition of Lonza's Swiss micronization plant underscores ongoing investments in advanced manufacturing technologies critical for high-quality pharmaceuticals.In ophthalmology, Belite Bio is advancing with promising Phase 3 results for tinlarebant in treating Stargardt disease—a rare genetic eye disorder. This success positions Belite to file for FDA approval, potentially expanding treatment options for this underserved patient population. Such advancements in targeted therapies emphasize the need for ongoing research in genetic disorders.Regeneron is betting $150 million on Tessera's gene writing technology targeting alpha-1 antitrypsin deficiency (AATD). This collaboration highlights the industry's growing interest in gene therapy as a frontier for treating rare diseases, marking a shift towards precision medicine where tailored genetic interventions offer hope for previously untreatable conditions. Regeneron's strategic move investing $275 million partnering with Tessera exploring gene editing capabilities—focusing on TSRA-196 targeting the SERPINA1 gene linked to AATD showcases potential advancing therapeutic options for genetic disorders through gene editing technologies offering new disease treatment avenues.AI-driven platforms were spotlighted at RSNA 2025 by industry leaders such as GE Healthcare, Philips, and Siemens. These innovations promise to revolutionize radiological workflows by enhancing diagnostic accuracy and operational efficiency through AI integration. As AI continues to permeate healthcare technologies, its potential to transform diagnostic processes marks a significant leap towards personalized medicine.Akebia Therapeutics' acquisition ofSupport the show

This week, we're diving into a flurry of major M&A activity from GE's $2.3B healthcare tech acquisition to Violia's $3B hazardous waste deal and a massive offshore wind farm stake sale by Denmark's Ørsted. But the spotlight is on Warner Bros. Discovery, where a high-stakes bidding war is heating up.With Paramount, Netflix, and Comcast all circling, Anthony and Piers unpack why the media giant rejected multiple multi-billion dollar offers and how strategic tension is being used to push up valuations. Is splitting the company more valuable than selling it whole? And what's the endgame for each suitor?(00:00) Rate Cut Hopes & Market Moves(07:34) M&A Roundup: Paint, Healthcare & Waste(10:27) Wind Power Play: Ørsted & Apollo(12:39) Warner Bros vs Paramount(24:34) Netflix & Comcast Join the Fray(32:00) Who Buys the Crown Jewels

Send us a textFew people enter the MedTech world because of a personal experience with the technology itself—but for Brent Lavin, that's exactly where it began. At just 23 years old, a CT scan that revealed an urgent medical issue also sparked a lifelong passion for medical technology and its power to save lives. That moment became the foundation of a career devoted to driving innovation in healthcare.Brent's early engineering work revealed an exceptional talent for connecting technical possibility with human need. Over the next two decades, he would lead cross-functional teams through more than 20 successful product launches, three mergers and acquisitions, and hundreds of millions of dollars in portfolio growth. His leadership—marked by curiosity, clarity, and conviction—has earned him accolades such as BD's Director of the Year and the CEO Excellence Award.Today, as Director of Strategic Growth at BD, Brent is responsible for identifying high-impact opportunities for both organic development and targeted acquisitions. Previously, he served as Director of Marketing and Product Management, where he led global teams across multiple disease states to record-breaking revenue growth, even in the face of pandemic-era supply chain challenges.Before joining BD, Brent spent years at GE Healthcare, where he honed his product management and global commercialization expertise, launching next-generation ultrasound systems that achieved over 200% year-over-year growth. His career reflects a rare blend of technical grounding, marketing strategy, and human-centered leadership—built on a mission to deliver meaningful innovation to clinicians and patients worldwide.Beyond the numbers, Brent is known for building high-performing teams and mentoring leaders who thrive in complex environments. Whether he's shaping go-to-market strategies, integrating newly acquired companies, or guiding engineers toward greater clarity and impact, his approach is grounded in purpose: to help people and teams reach their full potential while bringing life-changing technologies to market. LINKS:Guest LinkedIn: https://www.linkedin.com/in/brent-lavin/ Aaron Moncur, hostDownload the Essential Guide to Designing Test Fixtures: https://pipelinemedialab.beehiiv.com/test-fixtureAbout Being An Engineer The Being An Engineer podcast is a repository for industry knowledge and a tool through which engineers learn about and connect with relevant companies, technologies, people resources, and opportunities. We feature successful mechanical engineers and interview engineers who are passionate about their work and who made a great impact on the engineering community. The Being An Engineer podcast is brought to you by Pipeline Design & Engineering. Pipeline partners with medical & other device engineering teams who need turnkey equipment such as cycle test machines, custom test fixtures, automation equipment, assembly jigs, inspection stations and more. You can find us on the web at www.teampipeline.us

O'Hare air traffic has finally topped pre-pandemic levels and appears on track to break a record this year. Crain's aviation reporter John Pletz discusses with host Amy Guth.Plus: One of downtown's biggest distressed loans goes up for sale, Chicago Fed's Goolsbee says he's uneasy about "front loading" rate cuts, GE HealthCare to buy Intelerad for $2.3 billion in cash and feds accuse Chicago crypto firm and its CEO of laundering $10 million. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send us a textIn the final episode of our Rethinking Phototherapy series, Ben speaks with Steve Falk, Chief Engineer of the Maternal Infant Care Strategic Business Unit at GE Healthcare. With more than three decades of engineering leadership, Steve has been instrumental in the development of landmark neonatal technologies, including the Giraffe Omnibed and Panda platforms.This conversation highlights the critical role of engineering in making phototherapy precise, reliable, and safe. Steve explains how advances in LED technology have transformed phototherapy devices, ensuring consistent irradiance and long product life. He describes how engineers translate clinical needs—wavelength, intensity, surface coverage, and distance—into product requirements, and how rigorous usability testing with clinicians shapes intuitive bedside tools. The discussion also explores innovation on the horizon, from refining intermittent phototherapy strategies to integrating technologies that simplify care and support earlier discharge.Listeners will gain a behind-the-scenes perspective on how engineering teams think about phototherapy as a true pharmacotherapy, and how collaboration between clinicians and industry can directly improve outcomes for newborns and families. This episode closes the series by reminding us that innovation in neonatal care happens not only in clinical practice, but also in the design labs where these essential tools are created.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Trust is the foundation for successfully integrating AI into healthcare systems. In this episode, Dr. Taha Kass-Hout, Global Chief Science and Technology Officer at GE Healthcare, shares how AI is transforming operational efficiency, clinical workflows, and patient outcomes across health systems. He highlights applications such as ambient AI for documentation, AI-driven hospital operations, and unified data infrastructures that ease clinicians' cognitive load. Through GE Healthcare's CareIntellect platform and collaborations with systems like HCA, Duke Health, and Queen's Health, hospitals have achieved measurable improvements, including a 22% boost in patient transfers and $20 million in savings. Dr. Kass-Hout also emphasizes the importance of trust, interoperability, and clinician co-design to ensure AI adoption is ethical, scalable, and effective. Tune in and learn how AI-powered infrastructure and trust-driven innovation are redefining the future of healthcare delivery! Resources Connect with and follow Taha Kass-Hout on LinkedIn. Follow GE Healthcare on LinkedIn and explore their website! Listen to Taha's previous episode on the podcast here Browse the GE Healthcare Research website.

if you have any feedback, please send us a text! Thank you!Dr. J.W. Beard, a UCSF-trained anesthesiologist and Chief Medical Officer of GE Healthcare's Patient Care Solutions division, joins the Vital Times podcast to discuss his remarkable career journey. As a member of the Board of the Anesthesia Patient Safety Foundation, Dr. Beard shares how his background in anesthesiology uniquely prepared him for leadership in the medical technology industry, and offers insights into bridging clinical practice and innovation. 

Max Milz is Group Vice President Connected Technology Solutions at Dentsply Sirona, leading its digital healthcare portfolio, which includes imaging, CAD/CAM, surgical equipment, and AI-based clinical software. A passionate tech leader, he previously spent 12 years at Siemens AG, including five years in China. He serves on the Advisory Board of the Value for Good Foundation and holds degrees from Harvard and Cambridge.   David Ferguson joined Dentsply Sirona as Senior Vice President, Global Business Units in March 2025. David Ferguson is a seasoned executive with extensive leadership experience in the medical device and healthcare industries. He has a strong track record of driving revenue growth, strategic transformation, and operational excellence across multiple global businesses. Most recently, he was President of Gore Medical, a unit of W.L. Gore. Previously, as EVP at Philips and President & CEO of Philips Respironics, he managed a global team of 6,000 people. At Baxter Healthcare, he led the global infusion therapy, IV solutions and patient monitoring business. He also held leadership roles at GE Healthcare. Mr. Ferguson is a Graduate of the Advanced Management Program of University of Chicago Booth School of Business and holds a PhD in Chemistry from Texas A&M University and Bachelor of Science in Biochemistry from David Lipscomb University. He has served on multiple boards, including AZBio, Philips PAC, and Baxter International Foundation, and is a co-inventor of two U.S. patents and author of ten peer-reviewed publications.

In this episode of The Lebanese Physicians Podcast, co-hosts Dr. Khalil Diab and Dr. Hamad Ali sit down with Dr. Firas Mahdi, Partner at LEK Consulting in Singapore, to explore the intersection of strategy, technology, and innovation in healthcare across Asia and the Middle East. From his beginnings in clinical medicine at AUBMC to leadership roles at GE Healthcare, Medtronic, and now LEK, Dr. Mahdi shares a remarkable global journey spanning Lebanon, the Gulf, and Southeast Asia. We discuss: How Singapore's hybrid public–private healthcare model achieves world-class outcomes Lessons for Middle Eastern health systems in value-based care and operational excellence The evolving role of MedTech and AI in shaping the future of healthcare Building purpose-driven careers and navigating non-clinical paths in medicine A rich conversation about healthcare transformation, professional reinvention, and the future of global health strategy — where East truly meets Middle East.  

In this episode of The Dish on Health IT, host Tony Schueth, CEO of Point-of-Care Partners (POCP), is joined by colleagues Brian Dwyer, POCP's Business Strategy Lead, and Seth Joseph, Managing Director at Summit Health Advisors, to unpack their takeaways from the HLTH25 conference in Las Vegas. Together, they reflect on the energy of the event, the conversations shaping the future of health IT, and interviews recorded live from Podcast Row.The trio kicks off by comparing notes on how HLTH has evolved from a flashy innovation show to something more grounded, a space where serious conversations about interoperability, investment, and operational impact are starting to take hold. Seth notes the event's “coming-of-age” moment, where hype gave way to maturity. Brian agrees, adding that the buzz of startups pitching and investors circling was balanced by a sense of realism about implementation and outcomes.AI dominated every conversation, but with a more pragmatic tone than in years past. The hosts discuss how AI is shifting from novelty to necessity, moving from “AI for AI's sake” to purpose-driven use cases. Interview clips from leaders like Taha Kass-Hout with GE Healthcare spotlight “agentic AI,” where autonomous systems could act as trusted colleagues in care delivery, even participating in tumor board decisions to help extend expertise to rural or underserved regions. The group connects this to the ongoing challenge of ensuring data quality and interoperability as the foundation for any AI success story.Laurie McGraw of Transcarent and Kyle Kiser of Arrive Health bring different but complementary perspectives. Laurie underscores AI's potential to bend the cost curve only if applied safely and effectively, while Kyle highlights the growing complexity of affordability and the need for intelligent systems to help patients and providers navigate fragmented benefits and prescription pricing. Seth and Brian note that the shift toward patient empowerment, fueled by AI and transparency, could signal a broader cultural change in healthcare where consumers wield more influence.The discussion expands into value-based care with insights from McKesson's John Beardsley, who questions whether the industry has truly cracked the code after two decades of running at value-based care and interoperability. John also raises an important tension: small innovators are doing exciting things with AI, but scaling those solutions across full workflows remains the real test. The hosts debate whether new payment models, potentially powered by AI-driven insights, could finally make value-based care viable.Policy and regulation also take center stage as Christopher Chen, MD, MBA, Chief Medical Officer at the Washington State Health Care Authority, shares how state and federal efforts are aligning to accelerate interoperability, reduce provider burden, and modernize prior authorization processes under CMS-0057. The hosts reflect on the importance of federal leadership to align incentives across payers, providers, and technology vendors, echoing lessons learned from the early days of ePrescribing.Other memorable interview moments include John Beardsley's commentary on the CMS Interoperability and Patient App Pledges and how better understanding how NCPDP and FHIR standards bridge pharmacy and clinical data silos could help move the needle. Brian and Seth build on that theme, envisioning a future where agentic AI and patient-facing apps work together to drive true engagement and accountability for health outcomes.In the final stretch, the hosts revisit recurring topics such as physician burnout, administrative burden, and structured data chaos, tying them back to the industry's broader need for smarter implementation and aligned incentives. From Christopher Chen's relaying an anecdote about seeing structured data turned into unreadable images that are faxed in to Arrive Health's use of AI to prevent unnecessary transactions, the episode surfaces a consistent theme: technology alone won't fix healthcare, but when paired with aligned incentives, collaboration, and business transformation, it can finally make measurable progress.The episode closes with optimism. Tony, Brian, and Seth agree that while the system is strained, it's also full of momentum, from maturing AI applications to government action and renewed industry alignment. As Tony puts it, “There's a lot to be hopeful about and a lot of work left to do.”Listen to the full episode to hear interviews from the HLTH25 floor, including thought leaders discussing interoperability, agentic AI, and the real-world changes needed to make healthcare innovation stick.Share The Dish on Health IT from Spotify, Apple Podcasts, or Healthcare NOW Radio, Watch extended clips on the POCP YouTube channel

In this episode of the Org Design Podcast, host Tim Brewer and guest cohost Rory Mustan sit down with John Deverill—former British Army lieutenant colonel, ex-GE Healthcare leader, and current NHS change-maker. John shares how the disciplines of military leadership translate into organizational agility, what healthcare can learn from the battlefield, and why most organizations evolve by accident rather than intentional design. From rethinking strategy as “what you actually do,” to building coalitions of the willing, to balancing tradition with innovation, John delivers a masterclass on leading through uncertainty. Whether you're running a hospital, a corporation, or a fast-growing team, this episode will challenge how you think about leadership, strategy, and organizational resilience. John Deverill - https://www.linkedin.com/in/john-deverill-a04a7b1 EODF - https://eodf.eu/ Functionly https://www.linkedin.com/company/functionly https://www.functionly.com/ Org Design Podcast https://www.linkedin.com/company/orgdesignpodcast https://www.functionly.com/org-design-podcast

HR Works Podcast: GE Healthcare on Healing Your People Strategy by HR Daily Advisor

What does it really take to become lean—not just do lean?This is the secret to transformational lean leadership that Larry Culp, CEO of GE and GE Aerospace shared with me on stage three years ago. In this special bonus episode, I want to share his insights and wisdom about leadership and lean culture with you.This bonus episode marks two milestones in my own Chain of Learning® journey: 

In this episode of Let's Combinate: Drugs + Devices, host Subhi Saadeh welcomes Mark Kramer, the founding director of FDA's Office of Combination Products (OCP). Mark takes us on a deep dive into the history of how combination products have been regulated in the U.S., starting with the Safe Medical Devices Act of 1990 and how the process evolved into the formation of OCP in 2002.We explore questions such as: What challenges did industry and the FDA face in the early days of combination products? How did the “Request for Designation” process come about, and how is regulatory identity determined? What is the “Primary Mode of Action” (PMOA) rule and why does it matter? How do user fees, cross-center coordination, and post-market regulations shape how combination products get to market and are monitored? Mark also highlights current regulatory gapssuch as cross-labeling and site registration issues that continue to impact developers.Whether you're working in med-tech, pharma, or regulatory affairs, this episode offers historical perspective, technical insights, and strategic take-aways for navigating the combination-product space. Tune in for a candid conversation with one of the leading figures in this field.Timestamps:00:00 Introduction & Guest Welcome00:35 Historical Background of Combination Products03:05 Creation of Office of Combination Products (OCP)04:29 Early Challenges and Developments04:54 MDUFA, PDUFA, User Fee Programs & Legislative Impact14:24 Defining Primary Mode of Action (PMOA)18:35 OCP's Role & Responsibilities26:49 Industry Adoption & Challenges38:48 Regulatory Gaps & Future Directions46:00 Conclusion & Contact InformationContact & Resources:Connect with Mark Kramer on LinkedIn or via email at Mark.Kramer@greenleafhealth.comMark Kramer is Principal of the Medical Devices & Combination Products regulatory practice at Eliquent Life Sciences (formerly Greenleaf Health). He has more than 35 years experience at FDA and in regulated industry. At FDA, he established and directed the Office of Combination Products and was a scientific reviewer and later supervisor of the premarket review of devices in a variety of medical discipline areas. Following his FDA career, he served as Regulatory Affairs Executive and Chief Regulatory Strategist at GE Healthcare and then as an independent regulatory consultant for over 10 years before joining Greenleaf. Mark served as a board member of the Regulatory Affairs Professionals Society (RAPS) and in 2021, he was awarded the RAPS Founders Award, the profession's highest honor, recognizing exemplary regulatory professionals who have shaped regulatory policy and practice and have made a positive impact on the profession.Subhi Saadeh is a Quality Professional and host of Let's Combinate. With a background in Quality, Manufacturing Operations and R&D he's worked in Large Medical Device/Pharma organizations to support the development and launch of Hardware Devices, Disposable Devices, and Combination Products for Vaccines, Generics, and Biologics. Subhi serves currently as the International Committee Chair for the Combination Products Coalition(CPC) and as a member of ASTM Committee E55 and also served as a committee member on AAMI's Combination Products Committee.For questions, inquiries or suggestions please reach out at letscombinate.com or on the show's LinkedIn Page.

Crain's residential real estate reporter Dennis Rodkin joins host Amy Guth to talk news from the local housing market, including Chicago's narrowing lead over U.S. home price growth.Plus: Fed cuts rates quarter point, sets end to balance-sheet runoff, GE HealthCare takes $100 million hit from tariffs, Kraft Heinz lowers sales outlook as CEO warns of worst consumer sentiment in decades and Mondelez also trims outlook, and a developer gets $94 million construction loan for the first phase of its Motorola campus remake.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

market-moving events. The spotlight is on tech with earnings from heavyweights like Microsoft, Google, Meta, and ServiceNow set to hit after the bell. The Fed announcement and Chair Powell's press conference are front and center today, followed by U.S.–China trade talks at tomorrow's APEC Summit. Markets are leaning into a positive narrative—particularly across the tech sector—while energy, healthcare, and materials trail behind. We'll break down the earnings movers, from CAT and GE Healthcare to CVS and Visa, and what all this means for the market's next move.

In this episode, Jan Beger, Global Head of AI Advocacy at GE Healthcare, shares his mission to bridge the gap between the conceptual promise and real-world impact of AI in healthcare. He stresses on the critical need to build AI literacy and trust among clinicians, executives, and students, and explains why a human-centric approach and strong change management are critical for successful adoption. Jan highlights GE's global AI literacy programs that train employees and clinicians on responsible use, practical applications, and critical evaluation of AI. He highlights how moving beyond pilots to strategic, systemwide deployment requires continuous education, executive engagement, and a focus on change management. He also spoke about GE's successes such as improved efficiency in software development and innovations like AI-guided handheld ultrasound devices that democratize imaging by supporting users of varied expertise, as well as the challenges of keeping AI tools robust and up-to-date. Jan addresses the future of the workforce, noting that adaptability and tech fluency will be essential as 70% of job skills evolve by 2030. He encourages healthcare leaders to see AI not just as technology, but as a transformative tool to enhance care and outcomes. Take a listen.

Dr. Linda Chu speaks with Dr. Andrew Trout, Professor of Radiology and Director of Clinical Research at Cincinnati Children's, and Dr. Erin Angel, Vice President of Research and Scientific Affairs at GE HealthCare. They discuss the unique challenges of pediatric imaging and how collaboration and technology are advancing care for young patients while improving imaging for all. Sponsored by GE HealthCare.

In this episode of the HR Leaders Podcast, we speak with Adam Holton, Chief People Officer at GE HealthCare, about the mindset shifts HR leaders need to harness AI, personalize learning, and lead with authenticity. Adam explains why example matters more than instruction, why democratized learning is changing leadership, and how AI can act like a “superpower” for HR teams. The conversation covers embedding AI into coaching, rethinking processes instead of just automating them, and creating sticky adoption through daily use cases.

What does it take to build intelligent systems that are not only AI-powered but also secure, scalable, and grounded in real-world needs? In this episode of Tech Talks Daily, I speak with Srinivas Chippagiri, a senior technology leader and author of Building Intelligent Systems with AI and Cloud Technologies. With over a decade of experience spanning Wipro, GE Healthcare, Siemens, and now Tableau at Salesforce, Srinivas offers a practical view into how AI and cloud infrastructure are evolving together. We explore how AI is changing cloud-native development through predictive maintenance, automated DevOps pipelines, and developer co-pilots. But this is not just about technology. Srinivas highlights why responsible AI needs to be part of every system design, sharing examples from his own research into anomaly detection, fuzzy logic, and explainable models that support trust in regulated industries. The conversation also covers the rise of hybrid and edge computing, the real challenges of data fragmentation and compute costs, and how teams are adapting with new skills like prompt engineering and model observability. Srinivas gives a thoughtful view on what ethical AI deployment looks like in practice, from bias audits to AI governance boards. For those looking to break into this space, his advice is refreshingly clear. Start with small, end-to-end projects. Learn by doing. Contribute to open-source communities. And stay curious. Whether you're scaling AI systems, building a career in cloud tech, or just trying to keep pace with fast-moving trends, this episode offers a grounded and insightful guide to where things are heading next. Srinivas's book is available on Amazon under Building Intelligent Systems with AI and Cloud Technologies, and you can connect with him on LinkedIn to continue the conversation.

Send us a textJoin us for an in-depth conversation with Bryant Foster, a human factors expert who's worked with industry giants like Google to make complex products simpler and safer. With a background in cognitive psychology, Bryant shares insights on designing user-friendly products, from surgical systems to smart thermostats, all while keeping the end user at the center of the design process.Main Topics:What drew Bryant into human factors and user experience designHow to define and achieve simplicity in product designAdvanced usability testing tools: eye tracking, pupilometry, and facial emotion analysisWhy users don't always give honest feedback and how to work around itProviding critical design feedback without demoralizing teamsCost-effective approaches to human factors testingSafety considerations in medical device designUse-related risk analysis and task analysis methodologiesLessons learned from working at Google XBuilding successful human factors consulting teamsAbout the guest: Bryant Foster is the Vice President of Human Factors and User Experience at Research Collective, a user-centered research consultancy serving clients from startups to major companies like GE Healthcare, Microsoft, and Medtronic. With over a decade of experience in applied psychology and usability research, he specializes in ensuring products are safe, intuitive, and user-focused.He holds a Master's in Applied Psychology (Human Factors) from Arizona State University and began his career at the Cognitive Engineering Research Institute, later working at Google X as a UX researcher. At Research Collective in Tempe, Arizona, he leads a team that uses methods like ethnography, eye tracking, and biometric analysis.In addition to his consulting work, Bryant mentors students and supports local entrepreneurs through programs like LEAP, blending scientific rigor with empathy in fields from medical devices to consumer tech.Links:Bryant Foster LinkedInResearch Collective WebsiteClick here to learn more about simulation solutions from Simutech Group.

In this episode, we explore how nonprofit organizations like LBDA are working alongside industry partners to shape the evolving landscape of dementia biomarkers—bridging scientific innovation with real-world care. Featuring an engaging conversation with Dr. Sudhir Sivakumaran, Dr. Kathleen Poston, and Dr. Dustin Dunham on clinical utility, patient-centered research, and the road to broader adoption of biomarkers in Lewy body dementia, Alzheimer's disease and related disorders. This episode is sponsored by GE HealthCare

A set of AI use cases within the medical space. David Meier, Asit Sharma, and Roland Rott discuss: The latest on GE Healthcare, of which GE Healthcare Imaging is a piece. How AI is used to create efficiency gains, AND How AI is used to boost patient outcomes. Hosts: David Meier and Asit Sharma Guest: Roland Rott Engineer: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

Shannon Watts is the founder of Moms Demand Action, a prominent grassroots organization fighting gun violence in the United States. She initially aspired to be an investigative journalist, and she earned a journalism degree but transitioned into a career in public relations, spending nearly two decades in corporate communications at companies like Anthem and GE Healthcare. After taking a step back from her career to become a stay-at-home mom, the Sandy Hook tragedy in 2012 spurred her into action, and she founded Moms Demand Action with a simple Facebook group. Leveraging her communications and branding expertise, she transformed the group into a powerful nationwide movement, now part of Everytown for Gun Safety, the largest gun violence prevention organization in the country, with nearly 11 million supporters. She has since been recognized as one of Time's 100 Most Influential People and a Forbes 50 Over 50 Changemaker. She's also authored books including Fight Like a Mother and Fired Up.Buy Shannon's new book here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.